These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7775156)

  • 1. Pretreatment with beta-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice.
    Carpenter GW; Carr DJ
    Immunopharmacology; 1995 Mar; 29(2):129-40. PubMed ID: 7775156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine-induced suppression of cytotoxic T lymphocyte activity in alloimmunized mice is not mediated through a naltrindole-sensitive delta opioid receptor.
    Carr DJ; Carpenter GW
    Neuroimmunomodulation; 1995; 2(1):44-53. PubMed ID: 7614260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen.
    Carpenter GW; Garza HH; Gebhardt BM; Carr DJ
    Brain Behav Immun; 1994 Sep; 8(3):185-203. PubMed ID: 7865891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic characterization of TAT72-transgenic mice: effects of morphine on cell-mediated immunity.
    Garza HH; Prakash O; Carr DJ
    Int J Immunopharmacol; 1994 Dec; 16(12):1061-70. PubMed ID: 7705968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity.
    Carpenter GW; Breeden L; Carr DJ
    Int J Immunopharmacol; 1995 Dec; 17(12):1001-6. PubMed ID: 8964649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.
    Scott M; Carr DJ
    J Pharmacol Exp Ther; 1996 Aug; 278(2):980-8. PubMed ID: 8768756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxicity of N,N-diethylaniline in mice: effect on natural killer activity, cytotoxic T lymphocyte activity, lymphocyte proliferation response and cellular components of the spleen.
    Li Q; Hirata Y; Piao S; Minami M
    Toxicology; 2000 Sep; 150(1-3):179-89. PubMed ID: 10996674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
    Kerkvliet NI; Shepherd DM; Baecher-Steppan L
    Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol ester effects on splenic lymphocyte composition and cytotoxic T cell activities of SSIN mice: a strain deficient in CD8+ T cells.
    Yoon HL; Singh KP; Ratner S; Reiners JJ
    Carcinogenesis; 1996 Dec; 17(12):2617-24. PubMed ID: 9006097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of light/dark recombinant human prolactin administration on the submaxillary lymph nodes and spleen activity of adult male mice.
    Esquifino AI; Arce A; Alvarez MP; Chacon F; Brown-Borg H; Bartke A
    Neuroimmunomodulation; 2004; 11(2):119-26. PubMed ID: 14758058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central alpha-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity.
    Carr DJ; Mayo S; Gebhardt BM; Porter J
    J Neuroimmunol; 1994 Aug; 53(1):53-63. PubMed ID: 8051298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8+ T cells and CD4+ T cells.
    Terao H; Harada M; Kurosawa S; Shinomiya Y; Ito O; Tamada K; Takenoyama M; Nomoto K
    Immunobiology; 1996 Jul; 195(2):172-86. PubMed ID: 8877394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a single administration of morphine or footshock stress on natural killer cell cytotoxicity.
    Shavit Y; Martin FC; Yirmiya R; Ben-Eliyahu S; Terman GW; Weiner H; Gale RP; Liebeskind JC
    Brain Behav Immun; 1987 Dec; 1(4):318-28. PubMed ID: 3453207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CD8+ cytotoxic T cells by immunization with killed influenza virus and effect of cholera toxin B subunit.
    Mbawuike IN; Wyde PR
    Vaccine; 1993 Sep; 11(12):1205-13. PubMed ID: 7903015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice.
    Carr DJ; Brockunier LL; Scott M; Bagley JR; France CP
    Immunopharmacology; 1996 Aug; 34(1):9-16. PubMed ID: 8880221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells.
    Mingari MC; Ponte M; Bertone S; Schiavetti F; Vitale C; Bellomo R; Moretta A; Moretta L
    Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1172-7. PubMed ID: 9448304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone antagonizes the analgesic and immunosuppressive effects of morphine in mice.
    Carr DJ; Gerak LR; France CP
    J Pharmacol Exp Ther; 1994 May; 269(2):693-8. PubMed ID: 8182537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic analysis of splenocyte subsets following acute morphine treatment in the rat.
    Fecho K; Lysle DT
    Cell Immunol; 1999 Aug; 195(2):137-46. PubMed ID: 10448013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.